🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Response and Material Removal

According to the social media company, the platform has removed problematic content and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and investing in enhancing compliance measures.

Online Trading Activities

Investigations also discovered communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.

After moments of joining one community, a vendor posted contact information, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about weight, health issues or past usage.

Item Information and Pricing

Within these communities, posts show dark colored packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20mg. When questioned how much time a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it actively monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly significant health risks”.